Patent · US Active

Medicaments

US8389555B2 · kind B2 · utility

0Cited by

1References

21Claims

0Family size

Assignee

Motac Neuroscience Limited · GB

Inventors

Holger Stark · Bad Homburg vor der Höhe, DE
Jukka Matti Leppanen · Kuopio, FI
Britta Caroline Sasse · Montréal, CA
Oliver Saur · Heppenheim, DE
Tim Kottke · Frankfurt am Main, DE
Michael Hill · Oldham, GB

Key dates

Filing date	Oct 28, 2008
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Apr 1, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound of formal (I) is described: wherein R1 and R2 are as defined in the text and wherein the compounds are intended for use in treating medical conditions characterized by an imbalance in dopamine receptor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.